Long-term effects of baroreflex function after stenting in patients with carotid artery stenosis

Chih-Cheng Huang1, Yi-Shan Wu, Tainsong Chen

  • 1Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan.

Insights

Carotid stenting patients show reduced baroreflex sensitivity, similar to those with severe carotid stenosis. This impairment likely stems from underlying conditions, not the procedure itself, with no lasting autonomic dysfunction observed post-stenting.

Area of Science:

  • Cardiology
  • Neurology
  • Autonomic Neuroscience

Background:

  • Baroreflex sensitivity is crucial for cardiovascular and cerebrovascular risk prognosis.
  • Long-term baroreflex function outcomes after carotid stenting remain largely uncharacterized.
  • Carotid stenosis poses significant risks, necessitating effective treatment strategies like stenting.

Purpose of the Study:

  • To evaluate baroreflex sensitivity and autonomic function in patients post-carotid stenting.
  • To compare autonomic function between stented patients, those with severe stenosis, and healthy controls.
  • To determine if carotid stenting impacts long-term baroreflex sensitivity.

Main Methods:

  • Non-invasive assessment of heart rate variability and cardiovascular autonomic function.
  • Inclusion of 22 adult patients post-carotid stenting.
  • Comparison with 22 healthy controls and 10 patients with severe carotid stenosis (risk controls).

Main Results:

  • Patients undergoing carotid stenting and risk controls exhibited significantly reduced baroreflex sensitivity (Valsalva method) compared to normal controls.
  • No significant difference in baroreflex sensitivity was found between the stenting and risk control groups.
  • Carotid stenting patients showed decreased heart rate response to deep breathing and head-up tilt versus normal controls.

Conclusions:

  • Reduced baroreceptor function in stented patients is likely attributable to underlying diseases, not the stenting procedure.
  • Carotid stenting does not appear to cause short-term parasympathetic hyperactivity.
  • The observed autonomic effects seem transient, suggesting potential for recovery or minimal long-term impact.

Related Concept Videos

Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...